Pacira Biosciences Inc
F:82P
Pacira Biosciences Inc
F:82P
Price:
17.7
EUR
Market Cap:
€823.9m
Balance Sheet
Balance Sheet Decomposition
Pacira Biosciences Inc
Pacira Biosciences Inc
Balance Sheet Decomposition is not available for
Pacira Biosciences Inc
Pacira Biosciences Inc
Balance Sheet
Pacira Biosciences Inc
Pacira Biosciences Inc
Currency: USD
| Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||
| Cash & Cash Equivalents |
12
|
7
|
26
|
46
|
10
|
13
|
38
|
57
|
36
|
54
|
133
|
78
|
100
|
586
|
104
|
153
|
277
|
|
| Cash Equivalents |
12
|
7
|
26
|
46
|
10
|
13
|
38
|
57
|
36
|
54
|
133
|
78
|
100
|
586
|
104
|
153
|
277
|
|
| Short-Term Investments |
0
|
0
|
0
|
30
|
31
|
60
|
119
|
102
|
137
|
257
|
251
|
214
|
422
|
71
|
185
|
125
|
208
|
|
| Total Receivables |
3
|
2
|
1
|
2
|
4
|
15
|
22
|
26
|
30
|
32
|
38
|
48
|
53
|
96
|
98
|
106
|
113
|
|
| Accounts Receivables |
3
|
2
|
1
|
2
|
4
|
15
|
22
|
26
|
30
|
32
|
38
|
48
|
53
|
96
|
98
|
106
|
113
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
2
|
2
|
2
|
1
|
12
|
16
|
29
|
62
|
31
|
41
|
49
|
58
|
65
|
99
|
96
|
104
|
125
|
|
| Other Current Assets |
2
|
2
|
2
|
3
|
3
|
4
|
6
|
6
|
9
|
7
|
8
|
11
|
12
|
15
|
15
|
22
|
22
|
|
| Total Current Assets |
19
|
13
|
31
|
83
|
61
|
107
|
214
|
253
|
243
|
391
|
478
|
409
|
652
|
866
|
498
|
510
|
745
|
|
| PP&E Net |
18
|
20
|
24
|
25
|
39
|
48
|
61
|
90
|
101
|
107
|
109
|
143
|
211
|
265
|
254
|
235
|
216
|
|
| PP&E Gross |
18
|
20
|
24
|
25
|
39
|
48
|
61
|
90
|
101
|
107
|
109
|
143
|
211
|
265
|
254
|
235
|
216
|
|
| Accumulated Depreciation |
3
|
5
|
6
|
8
|
12
|
13
|
20
|
25
|
38
|
49
|
62
|
75
|
78
|
85
|
118
|
135
|
133
|
|
| Intangible Assets |
13
|
11
|
9
|
5
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
104
|
97
|
624
|
541
|
483
|
426
|
|
| Goodwill |
0
|
0
|
0
|
0
|
8
|
10
|
24
|
31
|
47
|
55
|
62
|
100
|
100
|
145
|
163
|
163
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
24
|
14
|
0
|
74
|
40
|
76
|
110
|
22
|
64
|
38
|
36
|
|
| Other Long-Term Assets |
0
|
1
|
3
|
1
|
1
|
3
|
3
|
0
|
1
|
1
|
1
|
0
|
106
|
153
|
160
|
144
|
130
|
|
| Other Assets |
0
|
0
|
0
|
0
|
8
|
10
|
24
|
31
|
47
|
55
|
62
|
100
|
100
|
145
|
163
|
163
|
0
|
|
| Total Assets |
51
N/A
|
44
-13%
|
67
+51%
|
114
+70%
|
112
-1%
|
170
+51%
|
326
+92%
|
388
+19%
|
392
+1%
|
628
+61%
|
689
+10%
|
831
+21%
|
1 275
+53%
|
2 075
+63%
|
1 681
-19%
|
1 574
-6%
|
1 554
-1%
|
|
| Liabilities | ||||||||||||||||||
| Accounts Payable |
12
|
7
|
4
|
3
|
3
|
3
|
7
|
9
|
8
|
15
|
14
|
13
|
10
|
11
|
15
|
16
|
19
|
|
| Accrued Liabilities |
1
|
1
|
1
|
3
|
10
|
17
|
26
|
35
|
33
|
39
|
44
|
73
|
76
|
127
|
92
|
65
|
78
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
99
|
103
|
104
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
3
|
6
|
8
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
150
|
375
|
34
|
9
|
202
|
|
| Other Current Liabilities |
3
|
4
|
6
|
17
|
1
|
2
|
4
|
2
|
4
|
2
|
2
|
22
|
17
|
9
|
7
|
9
|
11
|
|
| Total Current Liabilities |
17
|
14
|
16
|
32
|
14
|
122
|
140
|
150
|
45
|
56
|
61
|
108
|
253
|
521
|
148
|
97
|
310
|
|
| Long-Term Debt |
4
|
26
|
75
|
20
|
26
|
0
|
0
|
0
|
109
|
276
|
291
|
306
|
313
|
675
|
656
|
514
|
384
|
|
| Other Liabilities |
22
|
27
|
24
|
13
|
6
|
6
|
15
|
20
|
19
|
17
|
17
|
62
|
89
|
149
|
103
|
93
|
82
|
|
| Total Liabilities |
43
N/A
|
67
+55%
|
115
+72%
|
65
-43%
|
46
-29%
|
129
+178%
|
155
+20%
|
169
+9%
|
173
+2%
|
349
+102%
|
368
+6%
|
476
+29%
|
655
+38%
|
1 345
+105%
|
906
-33%
|
704
-22%
|
775
+10%
|
|
| Equity | ||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
78
|
110
|
137
|
180
|
233
|
296
|
310
|
308
|
346
|
389
|
388
|
399
|
254
|
212
|
149
|
107
|
206
|
|
| Additional Paid In Capital |
86
|
87
|
89
|
229
|
298
|
338
|
481
|
527
|
565
|
669
|
710
|
754
|
873
|
942
|
924
|
977
|
1 009
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
25
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
8
N/A
|
23
N/A
|
48
-111%
|
48
N/A
|
66
+36%
|
41
-37%
|
171
+315%
|
218
+28%
|
219
+0%
|
280
+28%
|
321
+15%
|
355
+10%
|
620
+75%
|
730
+18%
|
775
+6%
|
870
+12%
|
778
-11%
|
|
| Total Liabilities & Equity |
51
N/A
|
44
-13%
|
67
+51%
|
114
+70%
|
112
-1%
|
170
+51%
|
326
+92%
|
388
+19%
|
392
+1%
|
628
+61%
|
689
+10%
|
831
+21%
|
1 275
+53%
|
2 075
+63%
|
1 681
-19%
|
1 574
-6%
|
1 554
-1%
|
|
| Shares Outstanding | ||||||||||||||||||
| Common Shares Outstanding |
17
|
17
|
17
|
25
|
33
|
34
|
36
|
37
|
38
|
41
|
41
|
42
|
44
|
45
|
46
|
46
|
46
|
|
Switch to:
Switch to:
See Also
Discover More
